Binoy Kar

11PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMetal organic frameworksMolecular medicineBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 25, 2025
Mitochondria-Targeting 1H-Imidazo[4,5-f][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as a Promising Avenue for In Vitro Genotoxicity and In Vivo Tumor Immunotherapy.

Binoy Kar, Ashikur Rahaman, Maynak Pal

|Feb 05, 2025
Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment.

Utpal Das, Shanooja Shanavas, Meena Jayaprakash

|Sep 13, 2024
Photostimulated Anticancer Activity of Mitochondria Localized Rhenium(I) Tricarbonyl Complexes Bearing 1H-imidazo[4,5-f][1,10]phenanthroline Ligands Against MDA-MB-231 Cancer Cells.

Binoy Kar, Priyankar Paira

|May 30, 2024
2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents.

Binoy Kar, Shanooja Shanavas, Arun Karmakar

|Mar 12, 2024
Re(I)[2-aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism.

Lavanya Thilak Babu, Utpal Das, Rishav Das

|Apr 10, 2023
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells.

Nilmadhab Roy, Shanooja Shanavas, Binoy Kar

Pageof 2

Frequent Collaborators

11 joint publications

Priyankar Paira

4 joint publications

Seshu Vardhan

4 joint publications

Suban K Sahoo

3 joint publications

Utpal Das